Novel MEIOB pathogenic variants including a homozygous non-canonical splicing variant, cause meiotic arrest and human non-obstructive azoospermia.
Xiaoyu ZhuKaiqin HuHuiru ChengHuan WuKuokuo LiYang GaoMingrong LvChuan XuHao GengQunshan ShenYunxia CaoXiao-Jin HeDongdong TangRui GuoPublished in: Clinical genetics (2023)
Non-obstructive azoospermia (NOA) is the most severe form of human male infertility, and the genetic causes of NOA with meiotic arrest remain largely unclear. In this study, we identified novel compound heterozygous MEIOB variants (c.814C > T: p.R272X and c.976G > A: p.A326T) and a previously undescribed homozygous non-canonical splicing variant of MEIOB (c.528 + 3A > C) in two NOA-affected individuals from two irrelevant Chinese families. MEIOB missense variant (p.A326T) significantly reduced protein abundance and nonsense variant (p.R272X) produced a truncated protein. Both of two variants impaired the MEIOB-SPATA22 interaction. The MEIOB non-canonical splicing variant resulted in whole Exon 6 skipping by minigene assay, which was predicted to produce a frameshift truncated protein (p.S111Rfs*32). Histological and immunostaining analysis indicated that both patients exhibited a similar phenotype as we previously reported in Meiob mutant mice, that is, absence of spermatids in seminiferous tubules and meiotic arrest. Our study identified three novel pathogenic variants of MEIOB in NOA patients, extending the mutation spectrum of the MEIOB and highlighting the contribution of meiotic recombination related genes in human fertility.
Keyphrases
- endothelial cells
- end stage renal disease
- copy number
- chronic kidney disease
- newly diagnosed
- prognostic factors
- pluripotent stem cells
- cell cycle
- type diabetes
- protein protein
- amino acid
- gene expression
- binding protein
- high throughput
- small molecule
- metabolic syndrome
- intellectual disability
- dna damage
- dna methylation
- patient reported outcomes
- young adults
- microbial community
- antibiotic resistance genes
- cell proliferation
- polycystic ovary syndrome
- insulin resistance
- patient reported